Peek behind the paper: disease-dependent drug delivery in allograft protection

Written by RegMedNet

In this feature, Praveen Vemula (inStem; Bangalore, India) peeks behind his review paper evaluating the current and future states of allograft preservation by employing novel, disease-dependent drug release technology. Please could you introduce yourself and your institute? I am an associate investigator at the Institute for Stem Cell Biology and Regenerative Science (inStem; Bangalore, India). My research interests center around developing novel biomaterials, bioengineering concepts and chemical entities to solve unmet clinical needs. I run an academic lab that focuses on translational clinical research with two main focuses: i) biomaterials and ii) chemical biology. In our biomaterials program we develop...

To view this content, please register now for access

It's completely free